Stage IVA Prostate Cancer AJCC v8 Completed Phase 1 Trials for Enzalutamide (DB08899)

IndicationStatusPhase
DBCOND0109674 (Stage IVA Prostate Cancer AJCC v8)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03751436Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate CancerTreatment